Our wide range of technologies and high throughput methodologies can support all stages of development, including method development, characterization, impurity profiling, comparability, lot release, stability and clinical assessment of wide range of biotherapeutic molecules (e.g., monoclonal antibodies, fusion proteins, recombinant proteins and peptides) and efficient product and process characterization through robust set of platform-based physico-chemical and bioassay methods.

Our highly streamlined method transfer approaches will aid in successful implementation and validation in Quality Control laboratories. With experience of delivering on variety of programs, we bring high-throughput analytical automation, with in-house analytical method development, bioassay development and end-to-end physicochemical and functional characterization of biologicals.

Stelis offers services to fulfil your needs through technology, agility and technical expertise.